Literature DB >> 864007

The presence of protein-bound gamma-carboxyglutamic acid in calcium-containing renal calculi.

J B Lian, E L Prien, M J Glimcher, P M Gallop.   

Abstract

The amino acid gamma-carboxyglutamic acid (Gla) is found in four blood-clotting proteins, in a bone protein, in kidney protein, and in the protein present in various ectopic calcifications. This paper reports the presence of Gla in the EDTA-soluble, nondialyzable proteins of calcium-containing renal calculi including calcium oxalate, hydroxyapatite, and mixed stores of apatite and struvite (MgNH4PO4). Calculi composed of pure struvite and those composed of only uric acid or cystine do not contain Gla. From calcium oxalate and hydroxyapatite stontes, a protein of about 17,000 daltons was obtained which contained about 40 residues of Gla per 1,000 amino acids. The amino acid composition of this protein had no apparent relationship to the Gla-containing bone protein or to the similarly-sized F1 fragment of prothrombin which contains about 64 residues of Gla per 1,000 amino acid residues. The Gla-rich protein in calcium-containing renal stones thus may be a different Gla-containing protein. These data as well as other studies demonstrating the presence of Gla in pathologically calcified tissues not normally containing Gla suggest that the Gla-containing proteins may be of considerable pathophysiological significance.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 864007      PMCID: PMC372328          DOI: 10.1172/JCI108739

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  ELECTRON MICROSCOPIC STUDY OF RENAL CALCIFICATION.

Authors:  J B CAULFIELD; P E SCHRAG
Journal:  Am J Pathol       Date:  1964-03       Impact factor: 4.307

2.  Characterization of a gamma-carboxyglutamic acid-containing protein from bone.

Authors:  P A Price; A A Otsuka; J W Poser; J Kristaponis; N Raman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

3.  The presence of gamma-carboxyglutamic acid in the proteins associated with ectopic calcification.

Authors:  J B Lian; M Skinner; M J Glimcher; P Gallop
Journal:  Biochem Biophys Res Commun       Date:  1976-11-22       Impact factor: 3.575

4.  Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels.

Authors:  A L Shapiro; E Viñuela; J V Maizel
Journal:  Biochem Biophys Res Commun       Date:  1967-09-07       Impact factor: 3.575

5.  Vitamin K-dependent gamma-carboxyglutamic acid formation by kidney microsomes in vitro.

Authors:  P V Hauschka; P A Friedman; H P Traverso; P M Gallop
Journal:  Biochem Biophys Res Commun       Date:  1976-08-23       Impact factor: 3.575

6.  The isolation of an EDTA-soluble phosphoprotein from mineralizing bovine dentin.

Authors:  A Veis; A R Spector; H Zamoscianyk
Journal:  Biochim Biophys Acta       Date:  1972-02-29

7.  Chemical character of proteins in rat incisors.

Authors:  W T Butler; J E Finch; C V Desteno
Journal:  Biochim Biophys Acta       Date:  1972-01-26

8.  The amino acid sequence of two O-phosphoserine containing tripeptides isolated from the organic matrix of embryonic bovine enamel.

Authors:  J Seyer; M J Glimcher
Journal:  Biochim Biophys Acta       Date:  1969-07-01

9.  Vitamin K dependent modifications of glutamic acid residues in prothrombin.

Authors:  J Stenflo; P Fernlund; W Egan; P Roepstorff
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

10.  The mode of action of vitamin K. Isolation of a peptide containing the vitamin K-dependent portion of prothrombin.

Authors:  G L Nelsestuen; J W Suttie
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

View more
  34 in total

1.  Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.

Authors:  H Shiraga; W Min; W J VanDusen; M D Clayman; D Miner; C H Terrell; J R Sherbotie; J W Foreman; C Przysiecki; E G Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

2.  Calcium urolithiasis: is it analogous to bone formation?

Authors:  C Y Pak
Journal:  Calcif Tissue Res       Date:  1978-12-08

Review 3.  Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase.

Authors:  C Vermeer
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

Review 4.  Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.

Authors:  William G Robertson
Journal:  Urolithiasis       Date:  2016-11-29       Impact factor: 3.436

5.  Amino acids in urine and plasma of urolithiasis patients.

Authors:  K Kohri; M Takada; Y Katoh; K Kataoka; M Iguchi; T Kurita
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

6.  Direct measurement of vitamin K-dependent enzymes in various isolated and cultured tumor and non-tumor cells.

Authors:  M A de Boer-van den Berg; M P Uitendaal; C Vermeer
Journal:  Mol Cell Biochem       Date:  1987-05       Impact factor: 3.396

7.  Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.

Authors:  Y Nakagawa; V Abram; J H Parks; H S Lau; J K Kawooya; F L Coe
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

8.  High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.

Authors:  C M Shanahan; N R Cary; J C Metcalfe; P L Weissberg
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

9.  Calcium oxalate nephrolithiasis and expression of matrix GLA protein in the kidneys.

Authors:  Aslam Khan; Wei Wang; Saeed R Khan
Journal:  World J Urol       Date:  2013-03-09       Impact factor: 4.226

10.  Identification of two major proteins of bovine pancreatic stones as immunoreactive forms of trypsinogens.

Authors:  A De Caro; L Multigner; H Vérine
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.